TEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024. The presentation will begin at 11:30 A.M. Eastern Time.
To access a live webcast of the presentation, visit Teva’s Investor Relations website at https://ir.tevapharm.com/Events-and-Presentations.
An archived version of the webcast will be available within 24 hours after the end of the live discussion.
About Teva
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a global pharmaceutical leader with a category-defying portfolio, harnessing our generics expertise and stepping up innovation to continue the momentum behind the discovery, delivery, and expanded development of modern medicine. For over 120 years, Teva's commitment to bettering health has never wavered. Today, the company’s global network of capabilities enables its ~37,000 employees across 58 markets to push the boundaries of scientific innovation and deliver quality medicines to help improve health outcomes of millions of patients every day. To learn more about how Teva is all in for better health, visit www.tevapharm.com.
Cautionary Note Regarding Forward-Looking Statements
This document and the presentation at the conference may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management’s current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause our future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements. Important factors that could cause or contribute to such differences include risks relating to: our ability to successfully compete in the marketplace including our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to sustain and focus our portfolio of generics medicines; our substantial indebtedness; our business and operations in general including the impact of global economic conditions and other macroeconomic developments and the governmental and societal responses thereto; compliance, regulatory and litigation matters; other financial and economic risks; and other factors discussed in our Quarterly Report on Form 10-Q for the second quarter of 2024 and in our Annual Report on Form 10-K for the year ended December 31, 2023, including in the sections captioned "Risk Factors.” Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.
IR Contacts | Ran Meir | +1 (215) 591-8912 |
Yael Ashman | +972 (3) 914 8262 | |
Sanjeev Sharma | +1 (973) 658 2700 | |
PR Contacts | Kelley Dougherty | +1 (973) 832-2810 |
Eden Klein | +972 (3) 906 2645 |
-
东莞市盛汇枫食品有限公司------滋养身心的美味秘诀品牌在追求健康与美丽的道路上,人们从未停止探索过。牛奶花胶,鲜炖燕窝,即食海参,作为备受青睐的滋补佳品,已其独特的魅力和丰富的营养价值,成为了许多人养生清单上的常2024-08-27
-
共铸辉煌,开启电源行业新篇章共铸辉煌,开启电源行业新篇章 尊敬的合作伙伴们, 在这个科技日新月异的时代,电源行业作为支撑现代工业体系的重要基石,正迎来前所未有的发展机遇。电源平台作为权威2024-08-27
-
Teva to Present at the Morgan Stanley 22nd Annual Global Healthcare ConferenceTEL AVIV, Israel, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis,2024-08-27
-
英诺包装:智能环保纸箱,守护每一段物流旅程在商品流通的世界里,纸箱包装制品扮演着至关重要的角色。它们不仅仅是简单的容器,更是物品的守护者,是传递价值与品质的使者,智能化的生产模式更好的满足个性化定2024-08-27
-
揭开格林东方3.0成功秘笈,多元增润让酒店业绩稳定增长!2024年的夏天,格林东方3.0酒店系列迎来了新的发展,一连串的新店开业接踵而至:从贵阳龙洞堡国际机场的核心枢纽,到新疆喀什市机场的门户新标;从西安市新城区火车站的繁2024-08-27